The high voltage, low current frequencies generated by the BioCharger NG platform ionize the noble gases into a plasma state, producing a field of EM frequencies enriched with plasma photon light.
Initially discovered by Russian medical Professor Alexander G. Gurvich in 1923 (Gurvich named them “mitogenetic rays”), then widely researched in Europe and the US in the 1930s, biophotons were subsequently rediscovered by German biophysicist Fritz-Albert Popp in 1974, who described them as “coherent bio-laser light emanating from the DNA of every living cell.”
Popp observed that all living organisms exhibit a bioluminescence or electromagnetic auric field that pervades the entire organism, and that living cells produce coherent light with a laser-like quality. He discovered that this coherence acts to regulate cellular metabolism, growth, and reproduction rates and that cells exhibit superconductive characteristics.
Popp considered biophotons to be packets of transmitted information stored in the light field inside and outside a living organism. The light field of the cell is continually receiving inputs (virtual photons) from the environment and continually outputting biophotons, particularly in the near ultraviolet range.
Therefore, if a cell or organ is lacking energy and malfunctioning, the flawed information causing the malfunction is stored in the bio-photonic light emitted from the organ/organism. By using the BioCharger unit (which internationally renowned scientist Gaston Naessans called a “Photon Accumulator” upon observation of its operation), the flawed information contained in the bio-photons of the DNA can be reprogrammed by the bio-photons emitted by the BioCharger ionized plasma. The sub-optimal condition then disappears.